SAN FRANCISCO / Feb 22, 2024 / Business Wire / Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it will participate in the following upcoming investor events.
Raymond James 45th Annual Institutional Investors Conference
Date: March 5, 2024
Fireside Chat Time: 2:50 pm ET/11:50 am PT
Speaker: Anna Bryson, Chief Financial Officer
Barclays 26th Annual Global Healthcare Conference
Date: March 13, 2024
Fireside Chat Time: 11:15 am ET/8:15 am PT
Speaker: Anna Bryson, Chief Financial Officer
About Doximity
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The Company's network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients. For more information, visit www.doximity.com.
| Last Trade: | US$60.08 |
| Daily Change: | -3.18 -5.03 |
| Daily Volume: | 1,678,087 |
| Market Cap: | US$8.230B |
February 06, 2025 November 07, 2024 October 31, 2024 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
